Rchr
J-GLOBAL ID:201901002408837357   Update date: May. 14, 2024

Shimosegawa Eku

Shimosegawa Eku | Shimosegawa Eku
Research field  (1): Radiology
Research theme for competitive and other funds  (12):
  • 2019 - 2022 Development of Nuclear Medicine Therapy targeting Cancer Stroma
  • 2019 - 2022 Development of imaging method for early pancreatic cancer by high-resolution PET using radiolabeled antibody
  • 2017 - 2020 Evaluation of anti-cancer drug delivery by means of positron emission tomography: a proposal for new strategy of cancer treatment
  • 2015 - 2018 The normal biodistribution of the short half life alpha radionuclide At-211 and the evaluation of thyroid cancer accumulation.
  • 2012 - 2017 Species difference in pharmacokinetics of widely used drugs: a PET microdosing study
Show all
Papers (351):
  • Shota Yamamoto, Yoshiko Okita, Hideyuki Arita, Takahiro Sanada, Mio Sakai, Atsuko Arisawa, Naoki Kagawa, Eku Shimosegawa, Katsuyuki Nakanishi, Manabu Kinoshita, et al. Qualitative MR features to identify non-enhancing tumors within glioblastoma’s T2-FLAIR hyperintense lesions. Journal of Neuro-Oncology. 2023
  • Tadashi Watabe, Kazuya Kabayama, Sadahiro Naka, Ryuku Yamamoto, Kazuko Kaneda, Satoshi Serada, Kazuhiro Ooe, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, et al. Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with89Zr or211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma. Journal of Nuclear Medicine. 2023. jnumed.123.266313-jnumed.123.266313
  • Tadashi Watabe, Naoko Ose, Sadahiro Naka, Eriko Fukui, Toru Kimura, Takashi Kanou, Soichiro Funaki, Hidetaka Sasaki, Takashi Kamiya, Kenta Kurimoto, et al. Evaluation of LAT1 Expression in Patients With Lung Cancer and Mediastinal Tumors: 18F-FBPA PET Study With Immunohistological Comparison. Clinical nuclear medicine. 2023. 48. 10. 853-860
  • Yuto Satake, Hideki Kanemoto, Shiho Gotoh, Shoshin Akamine, Takashi Suehiro, Keiko Matsunaga, Eku Shimosegawa, Kenji Yoshiyama, Takashi Morihara, Kohji Mori, et al. Cerebrospinal fluid amyloid beta with amyloid positron emission tomography concordance rates in a heterogeneous group of patients including late-onset psychotic disorders: a retrospective cross-sectional study. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society. 2023
  • Yuto Satake, Hideki Kanemoto, Daiki Taomoto, Takashi Suehiro, Fuyuki Koizumi, Shunsuke Sato, Tamiki Wada, Keiko Matsunaga, Eku Shimosegawa, Shiho Gotoh, et al. Characteristics of very late-onset schizophrenia-like psychosis classified with the biomarkers for Alzheimer's disease: a retrospective cross-sectional study. International psychogeriatrics. 2023. 1-14
more...
MISC (212):
  • Fumihiko Soeda, Hiroki Kato, Kuriko Kagitani-Shimono, Haruhiko Kishima, Masako Taniike, Keiko Matsunaga, Tadashi Watabe, Mitsuaki Tatsumi, Eku Shimosegawa, Jun Hatazawa. Comparison of the Performances of 18F-FDG PET and 11C-DPA713 PET in Patients with Symptomatic Focal Epilepsy. JOURNAL OF NUCLEAR MEDICINE. 2021. 62
  • 増渕美穂, 小俣陽久, 越川七星, 片岡淳, 加藤弘樹, 豊嶋厚史, 寺本高啓, 松永恵子, 神谷貴史, 渡部直史, et al. Development and demonstration of new imaging methods using wide-band X ray and gamma ray. 応用物理学会秋季学術講演会講演予稿集(CD-ROM). 2021. 82nd
  • 渡部直史, 植村元秀, 永原啓, 添田文彦, 仲定宏, 佐々木秀隆, 神谷貴史, 加藤弘樹, 巽光朗, 下瀬川恵久, et al. DWIBSで異常所見なく,PSMA-PETで再発病変が同定された前立腺癌症例の検討. 核医学(Web). 2021. 58. 1
  • 仲定宏, 仲定宏, 渡部直史, LINDNER Thomas, 栗本健太, 若原正晴, MOORE Melissa, 巽光朗, 下瀬川恵久, VALLA Frank Jr, et al. カセット式合成装置を用いた[18F]FAPI-74製造プロセスの最適化-安定した臨床供給を目指して-. 核医学(Web). 2021. 58. Supplement
  • 渡部直史, 植村元秀, 添田文彦, 仲定宏, 佐々木秀隆, 神谷貴史, 下瀬川恵久, 加藤弘樹, 野々村祝夫, GIESEL Frederik L. 前立腺癌の生化学的再発における[18F]PSMA-1007PETの有用性. 核医学(Web). 2021. 58. Supplement
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page